Search

Your search keyword '"Gouw, Samantha C"' showing total 238 results

Search Constraints

Start Over You searched for: Author "Gouw, Samantha C" Remove constraint Author: "Gouw, Samantha C"
238 results on '"Gouw, Samantha C"'

Search Results

1. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology

2. Psychometrics of patient-reported outcomes measurement information system in von Willebrand disease, inherited platelet function disorders, and rare bleeding disorders

3. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)

5. Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banks

8. Patients’ and health care providers’ perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study

9. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients

10. Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B

12. Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress

15. SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders

16. The bleeding phenotype in people with nonsevere hemophilia

17. Joint status of patients with nonsevere hemophilia A

20. Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study

21. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A

22. Validation of PROMIS Profile‐29 in adults with hemophilia in the Netherlands

23. Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019

24. Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study

25. Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

26. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018

27. The factor VIII treatment history of non‐severe hemophilia A

29. Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study

30. Harmonizing patient-reported outcome measurements in inherited bleeding disorders with PROMIS

31. Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections

32. Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B

33. Anti-rituximab antibodies affect pharmacokinetics and pharmacodynamics of rituximab in children with immune-mediated diseases

35. Little discrepancy between one-stage and chromogenic FVIII/IX assays in a large international cohort of persons with non-severe hemophilia A and B

36. Colorectal Cancer Screening in Patients with Inherited Bleeding Disorders: High Cancer Detection Rate in Hemophilia Patients

37. Colorectal Cancer Screening in Patients with Inherited Bleeding Disorders: High Cancer Detection Rate in Hemophilia Patients

39. Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study

40. Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting

42. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

44. SYMPHONYconsortium: Orchestrating personalized treatment for patients with bleeding disorders

47. Validation of the pedHALshort and HALshort in Dutch children and adults with haemophilia.

48. Prophylactic anticoagulation in children receiving home parenteral nutrition.

50. Patient‐centred care in haemophilia: patient perspectives on visualization and participation in decision‐making

Catalog

Books, media, physical & digital resources